Novartis has launched a new initiative to help provide access to affordable medicines to treat the major symptoms of COVID-19, a critical need in the absence of a vaccine or curative treatment. Inflammation and respiratory problems linked to COVID-19 can cause severe medical complications and can lead to death in some people. A portfolio of 15 generic and over-the-counter medicines from Sandoz division will be sold at zero-profit to governments in up to 79 eligible countries during the pande...